FDA Panel To Discuss New Drug Label Warnings
A panel of U.S. Food and Drug Administration outside advisers is set to discuss whether Baxter International Inc. should follow the FDA's recommendation to revise the labeling for its inhaled anesthetic...To view the full article, register now.
Already a subscriber? Click here to view full article